1. Home
  2. PXED vs PCRX Comparison

PXED vs PCRX Comparison

Compare PXED & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PXED

Phoenix Education Partners Inc.

N/A

Current Price

$30.16

Market Cap

1.0B

Sector

Real Estate

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.50

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXED
PCRX
Founded
1976
2006
Country
United States
United States
Employees
3400
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
PXED
PCRX
Price
$30.16
$23.50
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$44.29
$30.25
AVG Volume (30 Days)
71.6K
516.5K
Earning Date
04-07-2026
04-30-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.07
Revenue
N/A
$541,533,000.00
Revenue This Year
$3.85
$6.78
Revenue Next Year
$4.49
$8.54
P/E Ratio
$11.20
$336.29
Revenue Growth
N/A
26.04
52 Week Low
$23.52
$18.80
52 Week High
$38.19
$27.64

Technical Indicators

Market Signals
Indicator
PXED
PCRX
Relative Strength Index (RSI) 53.45 49.85
Support Level $28.40 $22.13
Resistance Level $30.85 $24.20
Average True Range (ATR) 1.37 1.02
MACD -0.01 -0.06
Stochastic Oscillator 57.47 42.93

Price Performance

Historical Comparison
PXED
PCRX

About PXED Phoenix Education Partners Inc.

Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: